Skip to content

Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens

A Prospective Randomized Controlled Study to Evaluate the Clinical Performance of OxyAqua Silicone Hydrogel Soft Contact Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03139201
Enrollment
36
Registered
2017-05-03
Start date
2016-09-21
Completion date
2016-12-08
Last updated
2017-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

silicone hydrogel soft contact lens

Brief summary

The objective of this study is to demonstrate that the OxyAqua silicone hydrogel soft contact lens could be prescribed as a supportive care for myopes.

Detailed description

This is a double blind randomized control study to evaluate a daily disposable contact lens. It is planned to have 30 evaluable subjects at least divided evenly among 3 independent PIs from one hospital. Each PI will enroll 12 subjects at least. The ration of evaluable test subjects to control subjects will be 2 to 1. The study lens will be dispensed randomly to subjects who have normal ocular health and conform to a set of criteria. It is necessary to wear the lens 8 hours a day and 5 days a week at least and follow up for one month (30 days). Data will be collected at baseline, 1 week, 2 week and 4 week of daily disposable modality including Adverse Reactions, Slit-lamp findings and Symptoms, Problems, and Complaints, vision acuity, keratometry change and reason for discontinuation.

Interventions

DEVICEOxyAqua

OxyAqua (olifilcon D) silicone hydrogel soft contact lens

DEVICESi-Hy

Si-Hy (oliflcon B) silicone hydrogel soft contact lens

Sponsors

Visco Vision Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects should have normal eyes and use no ocular medications. They may have worn contact lenses previously, provided their eyes are shown to be normal at the start of the investigation. A normal eye is defined as having the following characteristics: 1. No anterior segment infection, inflammation or abnormality. 2. No other active ocular or systemic disease that would contraindicate contact lens wear; and 3. No medications that would contraindicate contact lens wear. * VA correctable to 0.1 LogMAR or better, with spherical lenses ranging in power from * 1.00 to -10.00 D myopia, astigmatism less than 2.00 D * Willing to comply with all study procedures and be available for the duration of the study. * Provide signed and dated informed consent form.

Exclusion criteria

* Have history of allergies that would contraindicate normal contact lens wear. * Have other active ocular or systemic disease such as, but not limited to: anterior uveitis (past or present), glaucoma, Sjögren's syndrome, lupus erythematosus, sclerodermas, keratoconus or type II diabetes, slip lamp findings greater than grade I (such as cornea or interstitial edema). * Have medications that would contraindicate contact lens wear. * Have had any cornea surgery. * Currently pregnant (to the best of the subject's knowledge), is lactating or is planning a pregnancy within the next 1 month. * Any active participation in another clinical trial within 30 days prior to this study. * The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures. * A known history of corneal hypoesthesia (reduced corneal sensitivity), corneal ulcer, corneal infiltrates or fungal infections. * A history of papillary conjunctivitis that has interfered with contact lens wear. * No monocular or monovision fits. * Alcoholic or Drug Abused.

Design outcomes

Primary

MeasureTime frameDescription
Log MAR visual acuity (VA)one monththe visual acuity corrected with contact lens could reach 0.1 or better

Secondary

MeasureTime frameDescription
Any slit lamp findings > grade 2over all follow-up visits for the 1 monthslit lamp findings on all dispensed eyes over all follow-up visits. Measured on a scale of 0-4 with 0=no findings and 4=sever findings.
Subjective response to comfort, symptoms and complaintsover all follow-up visits for the 1 monthsubjective ratings of comfort, symptom and complaints using a scale of 0=severe stinging/Burning to 5=No stinging/Burning for each eye

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026